MammoStar™ STAR1121Recalls & reported problems

Carbon Medical Technologies, Inc. · Biopsy Site Identifier · Class 2 · Implant

All models of MammoStar (11)

Data updated Oct 16, 2026 from official FDA records · Editorial policy

Adverse event reports: 1
Deaths reported: 0
Injuries reported: 1
Recalls naming it: 0

Summary

The FDA's MAUDE database contains 1 adverse event report that list this exact device (DI 00858015005417), received between May 27, 2024 and May 27, 2024 — classified as 1 injury.

The most frequently reported specific device problem is “Patient-Device Incompatibility” (1 report).

Reports come from manufacturers, hospitals and patients and are not verified by the FDA. A report does not prove the device caused the event, and counts can't be used to compare devices or estimate failure rates. What reports can and can't tell you · How this data works · Data updated Oct 16, 2026.

Reports received per month

Last 36 months. The most recent month may be incomplete.

Most reported problems

Device problems

Patient-Device Incompatibility1

Patient problems

Foreign Body Reaction1

Recent adverse event reports

The 1 most recent of 1 reports, in the reporter's own words as published by the FDA.

InjuryMay 27, 2024Patient-Device Incompatibility; Patient-Device Incompatibility
A RETROSPECTIVE CHART REVIEW POST MARKET CLINICAL FOLLOW-UP STUDY REPORTED THAT A FOREIGN BODY REACTION WAS OBSERVED WITH A PROBABLE ASSOCIATION. CLINICAL MANAGEMENT INCLUDED SURGERY RESULTING IN A PARTIAL RECOVERY. IT WAS NOTED THAT THE TISSUE MARKER WAS USED IN THE PRESENCE OF A BREAST IMPLANT. THE PROCEDURE WAS CARRIED OUT DESPITE THE PRESENCE OF AN INFECTION, WHICH IS A KNOWN RISK FACTOR.
Patient problems: Foreign Body Reaction
MAUDE report 19399286 ↗

Device details

UDI-DI	`00858015005417`
Brand	MammoStar™
Model	STAR1121
Company	Carbon Medical Technologies, Inc.
Product code	NEU · Marker, Radiographic, Implantable
Class	Class 2
FDA submission	None listed
Implant	Yes
Rx / OTC	Prescription
Single use	Yes
Sterile	Yes
MRI safety	MR Safe
Status	In Commercial Distribution
Record updated	Sep 18, 2023

Device type (GMDN): Radiological image marker, implantable

A device intended to be implanted within the body, either temporarily or permanently, to create identifying marks that can be seen on radiographic film or digital images. It is typically in the form of a wire, needle, bead, clip, stent-like tube, washer or fluid, and used to locate and delineate a tumour, lesion, or other site of interest. It is made from materials compatible with the imaging system with which it is intended to be used [e.g., magnetic resonance imaging (MRI), x-ray, or nuclear medicine]; it may be intended for use during radiotherapy procedures.

Other Marker, Radiographic, Implantable devices

BioZorb F0202
Hologic, Inc. · MARKER, RADIOGRAPHIC, IMPLANTABLE
2 recalls192 reports
BioZorb F0221
Hologic, Inc. · MARKER, RADIOGRAPHIC, IMPLANTABLE
3 recalls15 reports
BioZorb F0203
Hologic, Inc. · MARKER, RADIOGRAPHIC, IMPLANTABLE
2 recalls51 reports
BioZorb F0231
Hologic, Inc. · MARKER, RADIOGRAPHIC, IMPLANTABLE
2 recalls19 reports
BioZorb F0303
Hologic, Inc. · MARKER, RADIOGRAPHIC, IMPLANTABLE
2 recalls19 reports
BioZorb F0304
Hologic, Inc. · MARKER, RADIOGRAPHIC, IMPLANTABLE
2 recalls19 reports
BioZorb F0404
Hologic, Inc. · MARKER, RADIOGRAPHIC, IMPLANTABLE
2 recalls6 reports
BioZorb F0331
Hologic, Inc. · MARKER, RADIOGRAPHIC, IMPLANTABLE
2 recalls4 reports

All Marker, Radiographic, Implantable devices →

Sources and updates

Device record: FDA GUDID, file dated Oct 13, 2026 · View this device in AccessGUDID ↗
Adverse event reports: FDA MAUDE, file dated Oct 14, 2026 · each report above links to its original FDA record
Recalls: FDA Medical Device Recalls, file dated Oct 16, 2026
Page last rebuilt: Oct 16, 2026. Data downloaded through openFDA, which notes it is not validated for clinical or regulatory use.

How reports and recalls are matched · Editorial policy · Report an error on this page